Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 34,365 | 2,871 | 2,764 | 11,476 | 22,100 |
| Gross Profit | 34,365 | 2,871 | 2,764 | 11,476 | 22,100 |
| Operating Expenses | 118,519 | 100,766 | 95,285 | 96,033 | 96,526 |
| Operating Income | -84,154 | -97,895 | -92,521 | -84,557 | -74,426 |
| Interest Expense | 61 | 92 | 98 | 108 | 72 |
| Other Income | 14,981 | 11,006 | 10,444 | 8,051 | 8,917 |
| Pre-tax Income | -69,234 | -86,981 | -82,175 | -76,614 | -65,581 |
| Net Income Continuous | -69,234 | -86,981 | -82,175 | -76,614 | -65,581 |
| Net Income | $-69,234 | $-86,981 | $-82,175 | $-76,614 | $-65,581 |
| EPS Basic Total Ops | -0.71 | -0.98 | -0.94 | -0.95 | -0.82 |
| EPS Basic Continuous Ops | -0.71 | -0.97 | -0.94 | -0.95 | -0.82 |
| EPS Diluted Total Ops | -0.71 | -0.98 | -0.94 | -0.95 | -0.82 |
| EPS Diluted Continuous Ops | -0.71 | -0.97 | -0.94 | -0.95 | -0.82 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.97 | -0.90 | -0.95 | -0.82 |
| EBITDA(a) | $-84,862 | $-97,908 | $-92,560 | $-84,594 | $-74,903 |